165 related articles for article (PubMed ID: 34161594)
1. Comparison of the Safety of Prophylactic Anticoagulants After Intracranial Surgery.
Bell JS; Florence TJ; Phillips HW; Patel K; Macaluso NJ; Villanueva PG; Naik PK; Kim W
Neurosurgery; 2021 Aug; 89(3):527-536. PubMed ID: 34161594
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin versus unfractionated heparin in pediatric traumatic brain injury.
van Erp IA; Gaitanidis A; El Moheb M; Kaafarani HMA; Saillant N; Duhaime AC; Mendoza AE
J Neurosurg Pediatr; 2021 Feb; 27(4):469-474. PubMed ID: 33578391
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
[TBL] [Abstract][Full Text] [Related]
4. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.
Kwiatt ME; Patel MS; Ross SE; Lachant MT; MacNew HG; Ochsner MG; Norwood SH; Speier L; Kozar R; Gerber JA; Rowell S; Krishnakumar S; Livingston DH; Manis G; Haan JM
J Trauma Acute Care Surg; 2012 Sep; 73(3):625-8. PubMed ID: 22929493
[TBL] [Abstract][Full Text] [Related]
5. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin prophylaxis 24 to 36 hours after degenerative spine surgery: risk of hemorrhage and venous thromboembolism.
Strom RG; Frempong-Boadu AK
Spine (Phila Pa 1976); 2013 Nov; 38(23):E1498-502. PubMed ID: 23873245
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism prophylaxis in patients undergoing cranial neurosurgery: a systematic review and meta-analysis.
Hamilton MG; Yee WH; Hull RD; Ghali WA
Neurosurgery; 2011 Mar; 68(3):571-81. PubMed ID: 21311292
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight heparin is associated with lower venous thromboembolism events than factor Xa inhibitors in patients with severe blunt trauma: a cohort study from the Trauma Quality Improvement Program.
Chan SY; Huang JF; Cheng CT; Hsu CP; Liao CH; Fu CY
Int J Surg; 2024 Jan; 110(1):280-286. PubMed ID: 37738013
[TBL] [Abstract][Full Text] [Related]
9. The incidence of venous thromboembolism following surgical resection of intracranial and intraspinal meningioma. A systematic review and retrospective study.
Fluss R; Kobets AJ; Inocencio JF; Hamad M; Feigen C; Altschul DJ; Lasala P
Clin Neurol Neurosurg; 2021 Feb; 201():106460. PubMed ID: 33444944
[TBL] [Abstract][Full Text] [Related]
10. Chemoprophylaxis for venous thromboembolism in pelvic and/or acetabular fractures: A systematic review.
Shu HT; Yu AT; Lim PK; Scolaro JA; Shafiq B
Injury; 2022 Apr; 53(4):1449-1454. PubMed ID: 35148902
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review of Safety and Cost-Effectiveness of Venous Thromboembolism Prophylaxis Strategies in Patients Undergoing Craniotomy for Brain Tumor.
Algattas H; Damania D; DeAndrea-Lazarus I; Kimmell KT; Marko NF; Walter KA; Vates GE; Jahromi BS
Neurosurgery; 2018 Feb; 82(2):142-154. PubMed ID: 28402497
[TBL] [Abstract][Full Text] [Related]
12. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
[TBL] [Abstract][Full Text] [Related]
13. Safety and comparative efficacy of initiating low-molecular-weight heparin within 24 hours of injury or surgery for venous thromboembolism prophylaxis in patients with spinal cord injury: a prospective TRACK-SCI registry study.
Lui A; Park C; Chryssikos T; Radabaugh H; Patel A; Aabedi AA; Ferguson AR; Torres Espin A; Mummaneni PV; Dhall SS; Duong-Fernandez X; Saigal R; Chou A; Pan J; Singh V; Hemmerle DD; Kyritsis N; Talbott JF; Pascual LU; Huie JR; Whetstone WD; Bresnahan JC; Beattie MS; Weinstein PR; Manley GT; DiGiorgio AM
Neurosurg Focus; 2023 Oct; 55(4):E17. PubMed ID: 37778033
[TBL] [Abstract][Full Text] [Related]
14. Lower Mortality and Morbidity with Low-Molecular-Weight Heparin for Venous Thromboembolism Prophylaxis in Spine Trauma.
Neifert SN; Chapman EK; Rothrock RJ; Gilligan J; Yuk F; McNeill IT; Rasouli JJ; Gal JS; Caridi JM
Spine (Phila Pa 1976); 2020 Dec; 45(23):1613-1618. PubMed ID: 33156289
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Strachan J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
[TBL] [Abstract][Full Text] [Related]
16. Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?
Jo J; Donahue J; Sarai G; Petroni G; Schiff D
Neuro Oncol; 2022 Mar; 24(3):455-464. PubMed ID: 34383073
[TBL] [Abstract][Full Text] [Related]
17. Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Arthroscopic Surgery and Anterior Cruciate Ligament Reconstruction: A Meta-analysis of Randomized Controlled Trials.
Zhu J; Jiang H; Marshall B; Li J; Tang X
Am J Sports Med; 2019 Jul; 47(8):1994-2002. PubMed ID: 30113231
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
19. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.
Junqueira DR; Perini E; Penholati RR; Carvalho MG
Cochrane Database Syst Rev; 2012 Sep; (9):CD007557. PubMed ID: 22972111
[TBL] [Abstract][Full Text] [Related]
20. Chemical venous thromboembolism prophylaxis in neurosurgical patients: an updated systematic review and meta-analysis.
Khan NR; Patel PG; Sharpe JP; Lee SL; Sorenson J
J Neurosurg; 2018 Oct; 129(4):906-915. PubMed ID: 29192859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
